Analysis of KIAA1549-BRAF fusion status in a case of rosette-forming glioneuronal tumor of the fourth ventricle (RGNT)

Neuropathology

Volumn 31, Issue 6, 2011, Pages 654-657

  Gessi, Marco ^a   Waha, Anke ^a   Setty, Prashanth ^a   Waha, Andreas ^a   Pietsch, Torsten ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

BRAF; Cerebellum; KIAA1549; Pilocytic astrocytomas; Rosette forming glioneuronal tumors

Indexed keywords

B RAF KINASE; GENE PRODUCT; VIMENTIN;

ADULT; ARTICLE; ASTROCYTOMA; BRAIN FOURTH VENTRICLE; BRAIN TUMOR; CEREBELLUM VERMIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; GENE FUSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; ROSETTE FORMATION; ROSETTE FORMING GLIONEURONAL TUMOR;

ADOLESCENT; BRAIN NEOPLASMS; CEREBRAL VENTRICLE NEOPLASMS; GANGLIOGLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 81955161241     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2011.01220.x     Document Type: Article

References (12)

1. Hainfellner JA, Scheithauer BW, Giangaspero F, Rosenblum MK. Rosette-forming glioneuronal tumour of the fourth ventricle. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System, 4th edn. Lyon: IARC Press, 2007; 115-116.
2. Rosenblum MK. The 2007 WHO Classification of Nervous System Tumors: newly recognized members of the mixed glioneuronal group. Brain Pathol 2007; 17: 308-313.
3. Komori T, Scheithauer BW, Hirose T. A rosette-forming glioneuronal tumor of the fourth ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor? Am J Surg Pathol 2002; 26: 582-591.
4. Kuchelmeister K, Demirel T, Schlörer E, Bergmann M, Gullotta F. Dysembryoplastic neuroepithelial tumour of the cerebellum. Acta Neuropathol 1995; 89: 385-390.
5. Jones DT, Kocialkowski S, Liu L etal. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 2008; 68: 8673-8677.
6. Jacob K, Albrecht S, Sollier C etal. Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours. Br J Cancer 2009; 101: 722-733.
7. Sievert AJ, Jackson EM, Gai X etal. Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol 2009; 19: 449-458.
8. Dougherty MJ, Santi M, Brose MS etal. Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro Oncol 2011; published online ahead of print.
9. Koch A, Waha A, Hartmann W etal. Elevated expression of Wnt antagonists is a common event in hepatoblastomas. Clin Cancer Res 2005; 11: 4295-4304.
10. Scheithauer BW, Silva AI, Ketterling RP, Pula JH, Lininger JF, Krinock MJ. Rosette-forming glioneuronal tumor: report of a chiasmal-optic nerve example in neurofibromatosis type 1: special pathology report. Neurosurgery 2009; 64: E771-E772.
11. Shah MN, Leonard JR, Perry A. Rosette-forming glioneuronal tumors of the posterior fossa. J Neurosurg Pediatr 2010; 5: 98-103.
12. Jones DT, Kocialkowski S, Liu L, Pearson DM, Ichimura K, Collins VP. Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549-BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene 2009; 20: 2119-2123.